Globe Biotech gets approval to produce Covid vaccine for trial
- Update Time : Wednesday, January 6, 2021
- 160 Time View
The Directorate General of Drug Administration (DGDA) has granted permission to Globe Biotech Limited, a Bangladeshi biotech firm, for producing Covid-19 vaccine for clinical trial.
Dr Asif Mahmud, in-charge of research and development at Globe Biotech, said that the approval was given on December 28.
Mentioning that the name of the vaccine will be Bangavax, he said that they will produce the vaccine doses as per protocol.
Globe Biotech Limited declared it had developed a Covid-19 vaccine on July 2 last year.
In October last year, the company announced the vaccine proved to be “effective” and “completely safe” after conducting trials on rats.
M. Abid Rahman, Chairman, Editorial Board
M. Abid Rahman, Executive Editor
A K Azad, Bangladesh Bureau Chief
The Weekly Bangladesh NY SANGBAD INTL. INC.
64 Central Ave. Garden City, NY 11040
Tel: 516-491-4207, E-mail: newswbny@gmail.com